Esophageal Cancer Market Report 2026

Esophageal Cancer Market Overview

• Esophageal Cancer market size has reached to $1.51 billion in 2025 • Expected to grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Incidence Of Esophageal Cancer Fuels Market Growth • Market Trend: Precision Medicine Revolutionizing Esophageal Cancer Market • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Esophageal Cancer Market?

Esophageal cancer refers to a type of cancer that arises in the cells lining the esophagus, the muscular tube that carries food and drinks from the neck to the stomach. This occurs when abnormal cells in the food pipe (esophagus) develop uncontrollably and cause cancer. The main types of esophageal cancer are esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others. Esophageal squamous-cell carcinoma is a type of esophageal cancer that arises from the squamous cells lining the esophagus. The treatment types include chemotherapy, targeted therapy, and others administered orally, parenterally, and others. The treatment products are distributed through hospital pharmacy, online pharmacy, and retail pharmacy channels used by hospitals, homecare, specialty centers, and others.

What Is The Esophageal Cancer Market Growth Forecast?

The esophageal cancer market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to precision oncology adoption, immunotherapy development, early screening initiatives, improved imaging technologies, personalized cancer care. Major trends in the forecast period include rising adoption of targeted cancer therapies, increased use of combination treatment approaches, growth in advanced stage cancer management, expansion of minimally invasive surgical procedures, emphasis on early detection and diagnosis.

Global Esophageal Cancer Market Segmentation

1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types 2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users Subsegments: 1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma, Advanced Squamous-Cell Carcinoma 2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma, Advanced Adenocarcinoma 3) By Other Types: Neuroendocrine Tumors, Sarcomas, Mixed Cell Type Carcinomas

What Is The Driver Of The Esophageal Cancer Market?

An increase in esophageal cancer is expected to propel the esophageal cancer market growth. Esophageal cancer is a malignancy that affects the esophagus, the tube-like structure connecting the throat to the stomach. As the incidence of esophageal cancer increases, there will be a higher demand for diagnostic procedures, such as endoscopy, imaging tests, and biopsies, to detect and confirm the presence of the disease. For instance, in 2023, according to the American Cancer Society, a US-based professional organization, there were 16,120 new deaths from esophageal cancer, and this number is projected to rise to 16,130 in 2024. Therefore, the increase in esophageal cancer is expected to drive the growth of the esophageal cancer industry.

Key Players In The Global Esophageal Cancer Market

Major companies operating in the esophageal cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., AbbVie Inc., Bayer AG, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Aslan Pharmaceuticals Ltd., Johnson & Johnson Services Inc., CStone Pharmaceuticals, Shanghai Henlius Biotech, Jiangsu Hengrui Medicine Co Ltd., Kyowa Kirin Co Ltd., Incyte Corporation.

Global Esophageal Cancer Market Trends and Insights

Major companies operating in the esophageal cancer market are focusing on product launches, such as precision medicine, to provide a tailored approach to effectively manage the risk of a future cancer diagnosis. Precision medicine is an innovative approach to medical treatment that tailors interventions, such as drugs and therapies, to individual patients based on their unique genetic, environmental, and lifestyle characteristics. For instance, in March 2023, Previse, a US-based biotechnology company specializing in diagnostics, medical devices, and early detection, launched Esopredict, a precision medicine solution that allows gastroenterologists to provide a tailored approach to effectively manage the risk of a future cancer diagnosis, potentially saving lives. This launch introduces a groundbreaking precision medicine solution, utilizing the EsoScore derived from Barrett’s esophagus cells, providing gastroenterologists with timely and accurate 5-year risk predictions for esophageal cancer, thereby enabling tailored patient management. This innovative product addresses a crucial unmet medical need by assisting healthcare providers in identifying patients at risk of progressing to high-grade dysplasia or esophageal cancer, revolutionizing the approach to treatment and significantly impacting the esophageal cancer market.

What Are Latest Mergers And Acquisitions In The Esophageal Cancer Market?

In January 2023, ProPhase Labs, Inc., a US-based next-generation biotech, genomics, and diagnostics company acquired rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test from Stella Diagnostics, Inc. With this acquisition, ProPhase Labs aims to enable healthcare providers to promptly initiate life-saving early treatment measures, such as performing an ablation procedure to eliminate precancerous cells. Stella Diagnostics, Inc. is a US-based molecular diagnostics organization focused on improving patient management strategies.

Regional Outlook

North America was the largest region in the esophageal cancer market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Esophageal Cancer Market?

The esophageal cancer market consists of revenues earned by entities by providing esophageal cancer treatment services such as esophagectomy, palliative care, and brachytherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal cancer market consists of sales of fluorouracil, capecitabine, cisplatin, epirubicin, and docetaxel. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Esophageal Cancer Market Report 2026?

The esophageal cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the esophageal cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.